Loading…

New insights into hidradenitis suppurativa diagnosis via salivary infrared biosignatures: A pilot study

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease which can lead to a prolonged physical disability. HS diagnosis is exclusively clinical with the absence of biomarkers. Our study aims at assessing the HS‐diagnostic potential of infrared spectroscopy from saliva, as a biofluid ref...

Full description

Saved in:
Bibliographic Details
Published in:Journal of biophotonics 2021-03, Vol.14 (3), p.e202000327-n/a
Main Authors: Derruau, Stéphane, Gobinet, Cyril, Untereiner, Valérie, Sockalingum, Ganesh D., Nassif, Aude, Viguier, Manuelle, Piot, Olivier, Lorimier, Sandrine
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease which can lead to a prolonged physical disability. HS diagnosis is exclusively clinical with the absence of biomarkers. Our study aims at assessing the HS‐diagnostic potential of infrared spectroscopy from saliva, as a biofluid reflecting the body's pathophysiological state. Infrared spectra from 127 patients (57 HS and 70 non‐HS) were processed by multivariate methods: principal component analysis coupled with Kruskal–Wallis or Mann–Whitney tests to identify discriminant spectral wavenumbers and linear discriminant analysis to evaluate the performances of HS‐diagnostic approach. Infrared features, mainly in the 1300 cm−1‐1600 cm−1 region, were identified as discriminant for HS and prediction models revealed diagnostic performances of about 80%. Tobacco and obesity, two main HS risk factors, do not seem to alter the infrared diagnosis. This pilot study shows the potential of salivary “liquid biopsy” associated to vibrational spectroscopy to develop a personalized medical approach for HS patients' management. Hidradenitis suppurativa (HS) is a disabling multifactorial skin disease, largely unknown, whose diagnosis is based on clinical symptoms and specific patient examination. Developing a diagnostic tool for early personalized care of HS patient is needed. This pilot study shows the potential of saliva based infrared spectroscopy (IR) to identify spectral signatures specific to HS, contributing to the clinical implementation of the concept of “liquid biopsy.”
ISSN:1864-063X
1864-0648
DOI:10.1002/jbio.202000327